Kayla Paulini

Ms. Kayla Paulini

McGill University, Montréal, Quebec, Canada
orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 July 2021 in PLOS Neglected Tropical Diseases
Verified
Journal Article
Open access
PDF file
JCJessica Carstens-Kass
Jessica Carstens-Kass
KPKayla Paulini
Kayla Paulini
PLPatrick Lypaczewski
Patrick Lypaczewski
GMGreg Matlashewski
Greg Matlashewski
The leishmanin skin test (LST) has been used for decades to detect exposure and immunity to the parasiteLeishmania, the causative agent of the neglected tropical disease leishmaniasis. In the LST,Leishmaniaantigen (leishmanin) is intradermally injected into the forearm. In an individual who has been previously infected, a delayed-type hypersensitivity (DTH) reaction results in a measurable induration at the site of the injection, indicating that previous exposure toLeishmaniahas resulted in the development of cell-mediated immunity. LST positivity is associated with long-lasting protective immunity against reinfection, most notably as reported for visceral leishmaniasis (VL). Despite efforts over the past few decades, leishmanin antigen is no longer produced under good manufacturing practice (GMP) conditions anywhere in the world. Consequently, the use of the LST in epidemiological studies has declined in favor of serological and molecular tests. In this review, we provide a historical overview of the LST and justification for the reintroduction of leishmanin. A GMP-grade leishmanin can be used to detect immunity in vivo by the LST and can be investigated for use in an interferon-γ release assay (IGRA), which may serve as an in vitro version of the LST. The LST will be a valuable tool for surveillance and epidemiological studies in support of the VL elimination programs and as a surrogate marker of immunity in vaccine clinical trials. Methods: A review of the literature was conducted using PubMed as the primary database, with MeSH terms “leishmanin skin test” OR “Montenegro test” OR “Montenegro skin test.” Articles written in English that describe the history or standardization of leishmanin, the use of leishmanin in an IGRA, or the use of the LST in epidemiological studies or vaccine trials were prioritized in our appraisal of the literature.

14 March 2024 in Clinical Microbiology Reviews
Verified
Journal Article
Closed access
DPDilhan J Perera
Dilhan J Perera
CKCal Koger-Pease
Cal Koger-Pease
KPKayla Paulini
Kayla Paulini
MDMohamed Daoudi
Mohamed Daoudi
MNMomar Ndao
Momar Ndao
SUMMARY: Schistosomiasis is a neglected tropical disease caused by the helminth Schistosoma spp. and has the second highest global impact of all parasites. Schistosoma are transmitted through contact with contaminated fresh water predominantly in Africa, Asia, the Middle East, and South America. Due to the widespread prevalence of Schistosoma , co-infection with other infectious agents is common but often poorly described. Herein, we review recent literature describing the impact of Schistosoma co-infection between species and Schistosoma co-infection with blood-borne protozoa, soil-transmitted helminths, various intestinal protozoa, Mycobacterium , Salmonella , various urinary tract infection-causing agents, and viral pathogens. In each case, disease severity and, of particular interest, the immune landscape, are altered as a consequence of co-infection. Understanding the impact of schistosomiasis co-infections will be important when considering treatment strategies and vaccine development moving forward.

22 January 2022 in iScience
Verified
Journal Article
Open access
PLPatrick Lypaczewski
Patrick Lypaczewski
LTLovlesh Thakur
Lovlesh Thakur
AJAklank Jain
Aklank Jain
SKSandhya Kumari
Sandhya Kumari
KPKayla Paulini
Kayla Paulini
MJManju Jain
Manju Jain
Leishmaniasis is a neglected tropical disease endemic in over 90 countries. The disease has two main pathologies; cutaneous leishmaniasis (CL) that generally self-heals, and visceral leishmaniasis (VL) that is fatal if untreated. The majority of VL cases, concentrated on the Indian subcontinent (ISC) and East Africa, are caused by Leishmania donovani. However, recent foci of CL on the ISC have been attributed as an atypical phenotype of L. donovani including a recent outbreak in Himachal Pradesh, India. Whole genome sequencing and phylogenetic analysis was undertaken to investigate the origins and genetic factors leading to this pathology atypical of L. donovani. Here we demonstrate the isolate from Himachal Pradesh is derived from a genetic hybridization between two independent L. donovani parents from the ‘Yeti’ ISC1 divergent clade of parasites, identified in the Nepalese highlands. This reveals that intraspecies L. donovani hybrids can give rise to a novel strain associated with CL.

2 November 2023 in Nature Communications
Verified
Journal Article
Open access
PDF file
RDRanadhir Dey
Ranadhir Dey
JAJalal Alshaweesh
Jalal Alshaweesh
KSKamaleshwar P. Singh
Kamaleshwar P. Singh
PLPatrick Lypaczewski
Patrick Lypaczewski
SKSubir Karmakar
Subir Karmakar
GMGreg Matlashewski
Greg Matlashewski
The leishmanin skin test was used for almost a century to detect exposure and immunity to Leishmania, the causative agent of leishmaniasis, a major neglected tropical disease. Due to a lack of antigen used for the intradermal injection, the leishmanin skin test is no longer available. As leishmaniasis control programs are advancing and new vaccines are entering clinical trials, it is essential to re-introduce the leishmanin skin test. Here we establish a Leishmania donovani strain and describe the production, under Good Laboratory Practice conditions, of leishmanin soluble antigen used to induce the leishmanin skin test in animal models of infection and vaccination. Using a mouse model of cutaneous leishmaniasis and a hamster model of visceral leishmaniasis, soluble antigen induces a leishmanin skin test response following infection and vaccination with live attenuated Leishmania major (LmCen-/-). Both the CD4+ and CD8+ T-cells are necessary for the leishmanin skin test response. This study demonstrates the feasibility of large-scale production of leishmanin antigen addressing a major bottleneck for performing the leishmanin skin test in future surveillance and vaccine clinical trials.

Verified
Journal Article
Open access
PDF file
KPKayla Paulini
Kayla Paulini
PLPatrick Lypaczewski
Patrick Lypaczewski
WZWen-Wei Zhang
Wen-Wei Zhang
DPDilhan J Perera
Dilhan J Perera
MNMomar Ndao
Momar Ndao
GMGreg Matlashewski
Greg Matlashewski
The protozoan parasite Leishmania donovani is a causative agent of the neglected tropical disease known as visceral leishmaniasis, which can be lethal when untreated. Studying Leishmania viru-lence factors is crucial in determining how the parasite causes disease and identifying new targets for treatment. One potential virulence factor is L. donovani’s abundantly secreted protein: secreted acid phosphatase (SAcP). Whole-genome analysis revealed that the sacp gene was present in three copies in wild type L. donovani. Using CRISPR-Cas9 gene editing; we generated a sacp gene knockout termed LdΔSAcP, which demonstrated a loss of both the SAcP protein and an associated reduction in secreted acid phosphatase activity. Genome sequencing confirmed the precise dele-tion of the sacp gene in LdΔSAcP and identified several changes in the genome. LdΔSAcP demonstrated no significant changes in promastigote proliferation or its ability to infect and survive in macrophages compared to the wildtype strain. LdΔSAcP also demonstrated no change in murine liver infection; however, survival was impaired in the spleen. Taken together these results show that SAcP is not necessary for the survival of promastigotes in culture but may support long-term survival in the spleen. These observations also show that the use of CRISPR gene editing and WGS together are effective to investigate the function and phenotype of complex potential drug targets such as multicopy genes.

17 October 2025 in The FEBS Journal
Verified
Journal Article
Open access
KPKayla Paulini
Kayla Paulini
HKHira Khursheed
Hira Khursheed
WZWen Wei Zhang
Wen Wei Zhang
IAIsabelle Aubry
Isabelle Aubry
GMGreg Matlashewski
Greg Matlashewski
PLPatrick Lypaczewski
Patrick Lypaczewski
Leishmania donovani is a causative agent of the neglected tropical disease known as visceral leishmaniasis or Kala Azar. This disease is lethal when untreated, with more than 90 000 cases annually. Little is known about magnesium regulation in these parasites despite magnesium being the second most abundant intracellular cation and universally required for normal cell function. L. donovani contains two protein tyrosine phosphatase (PTP) proteins (PTP1 and PTP2) and a DUF21 protein (domain of unknown function 21), which are respectively homologous to mammalian PRL [phosphatases of regenerating liver; also known as protein tyrosine phosphatase type IVA (PTP4A)] and mammalian transmembrane protein CNNM (cyclin M family). In mammalian cells, the PRL and CNNM multiprotein complex has been shown to sense and modulate intracellular magnesium levels. Herein, we revealed that L. donovani PTP1 and DUF21 can also form a specific protein complex. Using CRISPR‐Cas9 gene editing, four L. donovani knockouts, LdΔPTP1, LdΔPTP2, a double knockout termed LdΔPTP1/2, and LdΔDUF21 have been generated. Magnesium‐dependent growth curves demonstrated that the LdΔPTP1/2 mutant could not survive in low magnesium and had a reduced level of survival in infected macrophages. In contrast, LdΔDUF21 is sensitive to high levels of magnesium and has an increased level of intracellular magnesium and an increased survival in macrophages compared to wild‐type L. donovani. Taken together, these observations provide evidence that, similar to the PRL and CNNM proteins in mammalian cells, PTP and DUF21 homologs in L. donovani have the ability to complex and respond to environmental changes in magnesium.